Армения - английски - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

delorbis pharmaceuticals ltd. - desloratadine - tablets film-coated - 5mg

Малта - английски - Medicines Authority

delorbis pharmaceuticals limited 17 athinon str, ergates industrial area, 2643 ergates, po box 28629, 2081 lefkosia, cyprus - film-coated tablet - desloratadine 5 mg - antihistamines for systemic use

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

gedeon richter (uk) ltd - desogestrel; ethinylestradiol - oral tablet - 150microgram ; 20microgram

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

gedeon richter (uk) ltd - desogestrel; ethinylestradiol - oral tablet - 150microgram ; 30microgram

Ирландия - английски - HPRA (Health Products Regulatory Authority)

gedeon richter plc - ethinylestradiol; desogestrel - film-coated tablet - 30mcg/150 microgram(s) - progestogens and estrogens, fixed combinations; desogestrel and ethinylestradiol

Ирландия - английски - HPRA (Health Products Regulatory Authority)

gedeon richter plc - ethinyloestradiol; desogestrel - film-coated tablet - 20mcg/150 microgram(s) - progestogens and estrogens, fixed combinations; desogestrel and ethinylestradiol

САЩ - английски - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - warfarin sodium (unii: 6153cwm0cl) (warfarin - unii:5q7zvv76ei) - warfarin sodium 2 mg - warfarin sodium tablets are indicated for: - •prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (pe). - •prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (af) and/or cardiac valve replacement. - •reduction in the risk of death, recurrent myocardial infarction (mi), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. limitations of use warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further extension of the formed clot and to prevent secondary thromboembolic complications that may result in serious and possibly fatal sequelae. warfarin sodium is contraindicated in: - •pregnancy warfarin sodium is contraindicated in women who are pregnant except in pregnant women with mechanical heart valves, who are at high risk of thromboembolism

САЩ - английски - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - warfarin sodium (unii: 6153cwm0cl) (warfarin - unii:5q7zvv76ei) - warfarin sodium 3 mg - warfarin sodium tablets are indicated for: - •prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (pe). - •prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (af) and/or cardiac valve replacement. - •reduction in the risk of death, recurrent myocardial infarction (mi), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. limitations of use warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further extension of the formed clot and to prevent secondary thromboembolic complications that may result in serious and possibly fatal sequelae. warfarin sodium is contraindicated in: - •pregnancy warfarin sodium is contraindicated in women who are pregnant except in pregnant women with mechanical heart valves, who are at high risk of thromboembolism